Interleukin-4 −33 C/T Gene Polymorphisms are not Associated with Type 2 Diabetes Mellitus

Authors

  • Milahayati Daulay Department of Physiology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Sumatera Utara, Indonesia
  • Mutiara Indah Sari Department of Biochemistry, Faculty of Medicine, Universitas Sumatera Utara, Medan, Sumatera Utara, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.5419

Keywords:

Diabetes, Gene, Interleukin, Polymorphisms, Sumatera Utara

Abstract

 

 BACKGROUND: Various studies have shown variations in the interleukin-4 (IL) gene associated with type 2 diabetes mellitus (T2DM) in different populations and ethnicities.

AIM: The objective of this study was to determine the genetic variation of the IL-4 −33 C/T gene in some T2DM patients compared with healthy control in Medan, Sumatera Utara province, Indonesia.

METHODS: DNA from T2DM patients and healthy control was isolated, then the determination of the IL-4 −33 C/T gene polymorphism was carried out using the polymerase chain reaction-restriction fragment length polymorphism technique.

RESULTS: In all samples of this study, IL-4 −33 C/T gene polymorphisms were found in patients with T2DM and healthy control but were not statistically significant.

CONCLUSION: The IL-4 −33 C/T gene polymorphism has no relationship with the incidence of T2DM in a portion of our population in Medan, Sumatera Utara province, Indonesia.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Sari MI, Daulay M, Widyawati T, Anggraini DR, Wahyuni DD, Syarifah S. The tumor necrosis factor-α _gene polymorphism (-308G/A) in Type 2 diabetes mellitus patients with tuberculosis infection. In: Proceedings of the 3rd International Conference on Mathematics, Science, Education and Engineering, Padang, Indonesia. United Kingdom: Institute of Physics Publishing; 2018. p. 1-6.

Neelofar K, Ahmad J, Ahmad A, Alam K. Study of IL4-590C/T and IL6-174G/C gene polymorphisms in Type 2 diabetic patients with chronic kidney disease in North Indian population. J Cell Biochem. 2017;118:1803-9. https://doi.org/10.1002/jcb.25853 PMid:27996163

Jinpon P, Jaroensutasinee M, Jaroensutasinee K. Risk assessment of Type 2 diabetes mellitus in the population of Chonburi, Thailand. Walailak J Sci Tech. 2017;14:25-33.

World Health Organization. Global Report on Diabetes. Paris: World Health Organization; 2016. p. 1-86.

International Diabetes Federation. Diabetes Atlas. 7th ed. Brussels, Belgium: International Diabetes Federation; 2015. p. 1-142.

American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2014;37:S81-90. https://doi.org/10.2337/dc14-s081 PMid:24357215

Politi C, Ciccacci C, D’Amato C, Novelli G, Borgiani P, Spallone V. Recent advances in exploring the genetic susceptibility to diabetic neuropathy. Diabetes Res Clin Pract. 2016;120:198-208. https://doi.org/10.1016/j.diabres.2016.08.006 PMid:27596057

Saxena M, Srivastava N, Banerjee M. Cytokine gene variants as predictors of Type 2 diabetes mellitus. Curr Diabetes Rev. 2018;14:307- 19. https://doi.org/10.2174/1573399813666170112145429 PMid:28081697

Abd Elneam AI, Mansour NM, Zaki NA, Taher MA. Serum interleukin-18 and its gene haplotypes profile as predictors in patients with diabetic nephropathy. Open Access Maced J Med Sci. 2016;4:324-8. https://doi.org/10.3889/oamjms.2016.074 PMid:27703550

Sheikhpour R. Diabetes and oxidative stress: The mechanism and action. Iran J Diabetes Obes. 2013;5:40-5.

Micheal S, Minhas K, Ishaque M, Ahmed F, Ahmed A. IL-4 gene polymorphisms and their association with atopic asthma and allergic rhinitis in Pakistani patients. J Investig Allergol Clin Immunol. 2013;23:107-11. PMid:23654077

Liang J, Liu Y, Xue R, Chen L, Chen H, Shao L, et al. Interleukin 4-590C/T (rs2243250) polymorphism is associated with increased risk of atopic dermatitis: Meta-analysis of case-control studies. Dermatitis. 2017;28:144- 51. https://doi.org/10.1097/der.0000000000000265 PMid:28169853

Qiu LJ, Ni J, Cen H, Wen PF, Zhang M, Liang Y, et al. Relationship between the IL-4 gene promoter-590C/T (rs2243250) polymorphism and susceptibility to autoimmune diseases: A meta-analysis. J Eur Acad Dermatol Venereol. 2015;29:48-55. https://doi.org/10.1111/jdv.12435 PMid:24628947

Navarro-González JF, Mora-Fernández C. The role of inflammatory cytokines in diabetic nephropathy. J Am Soc Nephrol. 2008;19:433-42. https://doi.org/10.1681/asn.2007091048 PMid:18256353

Voehringer D, Reese TA, Huang X, Shinkai K, Locksley RM. Type 2 immunity is controlled by IL-4/IL-13 expression in hematopoietic non-eosinophil cells of the innate immune system. J Exp Med. 2006;203:1435-46. https://doi.org/10.1084/jem.20052448 PMid:16702603

Francés DE, Ingaramo PI, Ronco MT, Carnovale CE. Diabetes, an inflammatory process: Oxidative stress and TNF-alpha involved in hepatic complication. J Biomed Sci Eng. 2013;6:645- 53. https://doi.org/10.4236/jbise.2013.66079

Banerjee M, Saxena M. Genetic polymorphisms of cytokine genes in Type 2 diabetes mellitus. World J Diabetes. 2014;5:493-504. https://doi.org/10.4239/wjd.v5.i4.493 PMid:25126395

Arababadi MK, Pourfathollah AA, Daneshmandi S, Hassanshahi G, Zrandi ER, Shamsizadeh A, et al. Evaluation of relation between IL-4 and IFN-γ _polymorphisms and Type 2 Diabetes. Iran J Basic Med Sci. 2009;12:100-4.

Završnik M, Letonja J, Makuc J, Šeruga M, Cilenšek I, Petrovič D. Interleukin-4 (IL4)-590C/T (rs2243250) gene polymorphism is not associated with diabetic nephropathy (DN) in Caucasians with Type 2 diabetes mellitus (T2DM). Bosn J Basic Med Sci. 2018;18:347-51. https://doi.org/10.17305/bjbms.2018.2688

Alsaid A, El-Missiry M, Hatata ES, Tarabay M, Settin A. Association of IL-4-590 C>T and IL-13-1112 C>T gene polymorphisms with the susceptibility to Type 2 diabetes mellitus. Dis Markers. 2013;35:243-7. https://doi.org/10.1155/2013/107470 PMid:24167373

Arababadi MK. Interleukin-4 gene polymorphisms in Type 2 diabetic patients with nephropathy. Iran J Kidney Dis. 2010;4:302-6. PMid:20852371

Ho KT, Shiau MY, Chang YH, Chen CM, Yang SC, Huang CN. Association of interleukin-4 promoter polymorphisms in Taiwanese patients with Type 2 diabetes mellitus. Metabolism. 2010;59:1717-22. https://doi.org/10.1016/j.metabol.2010.04.010 PMid:20580039836

Downloads

Published

2020-10-22

How to Cite

1.
Daulay M, Sari MI. Interleukin-4 −33 C/T Gene Polymorphisms are not Associated with Type 2 Diabetes Mellitus. Open Access Maced J Med Sci [Internet]. 2020 Oct. 22 [cited 2024 Apr. 19];8(A):833-6. Available from: https://oamjms.eu/index.php/mjms/article/view/5419

Funding data

Most read articles by the same author(s)

1 2 > >>